| ROP |
Report |
Adjusted diluted EPS |
IN-LINE |
pred ~$5.28 vs. cons $5.283 |
LOW |
| ROP |
Report |
Revenue |
IN-LINE |
pred ~$2.100B vs. cons $2.097B |
LOW |
| ROP |
Report |
Organic revenue growth |
IN-LINE |
pred ~4.30% vs. cons 4.32% |
LOW |
| ROP |
Guide |
FY26 adjusted diluted EPS |
UNCHANGED |
guide ~$21.80-$22.05 vs. cons $21.938 |
LOW |
| ROP |
Guide |
FY26 organic revenue growth |
LOWER |
guide ~5-6% vs. cons 5.62% |
LOW |
| ROP |
Guide |
Q3 adjusted diluted EPS |
UNCHANGED |
guide ~$5.60-$5.65 vs. cons $5.675 |
LOW |
| ROP |
Return |
Day-1 residual (stock − beta × S&P 500) |
-2.0% |
— |
LOW |
| ROP |
Return |
5-day cumulative residual |
-3.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — modest implicit organic-growth reset |
LOW |